Table 3.
Regular immune monitoring panel of the patients.
| Parameters | All (n = 30) | MP (n = 19) | SP (n = 11) | P |
|---|---|---|---|---|
| Monocyte HLA-DR, MFI ± SD | 1335 ± 205.0 | 1671.00 ± 285.80 | 783.60 ± 184.60 | 0.0329 |
| Neutrophil CD64, MFI ± SD | 595.4 ± 86.70 | 522.10 ± 112.20 | 715.5 ± 134.80 | 0.2872 |
| CD3+ T cells/TBNK, mean ± SD (%) | 77.72 ± 1.82 | 76.09 ± 2.41 | 80.38 ± 2.65 | 0.2583 |
| CD3+ T cells, mean ± SD (/μL) | 707.38 ± 77.05 | 819.2 ± 96.83 | 524.5 ± 111.1 | 0.0621 |
| CD8+ T cells/TBNK, mean ± SD (%) | 34.12 ± 1.80 | 32.45 ± 1.79 | 37.06 ± 3.69 | 0.2207 |
| CD8+ T cells, median ± IQR (/μL) | 313 ± 245 | 335.50 ± 204.75 | 189 ± 241.50 | 0.2038# |
| CD4+ T cells/TBNK, mean ± SD (%) | 39.75 ± 1.87 | 41.60 ± 2.60 | 36.73 ± 2.33 | 0.2111 |
| CD4+ T cells, mean ± SD (/μL) | 367.14 ± 44.49 | 451.4 ± 58.41 | 229.2 ± 45.33 | 0.0125 |
| NK cells/TBNK, mean ± SD (%) | 11.23 ± 1.44 | 12.99 ± 1.90 | 8.475 ± 1.98 | 0.1301 |
| NK cells, median ± IQR (/μL) | 80 ± 112 | 110.50 ± 125.75 | 45 ± 53.50 | 0.0249# |
| B cells/TBNK, median ± IQR (%) | 7.78 ± 8.84 | 7.03 ± 10.38 | 8.46 ± 6.20 | 0.5801# |
| B cells, median ± IQR (/μL) | 77 ± 102 | 93 ± 92.25 | 41 ± 112 | 0.5724# |
| CD4/CD8 ratio, median ± IQR | 1.11 ± 0.83 | 1.45 ± 1.01 | 0.99 ± 0.29 | 0.2906# |
#Tested by the Mann-Whitney U test; others were tested by the unpaired t-test. HLA-DR: human leukocyte antigen-DR; MFI: median fluorescence intensity; SD: standard deviation; IQR: interquartile range; TBNK: T, B, and NK cells; NK cells: natural killer cells.